Search Within

Helen Hyeong-Eun Won

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (51)
  2. Journal Article (50)
  3. Research Letter (1)
Groups
  1. GSK Faculty (102)
  2. Human Oncology and Pathogenesis Program (102)
  3. Department of Pathology and Laboratory Medicine (98)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (96)
  5. Department of Medicine (75)
  6. Solid Tumor Oncology Division (72)

More Groups

People
  1. Michael Berger (94)
  2. David Solit (30)
  3. Marc Ladanyi (27)
  4. David Hyman (18)
  5. Hikmat Al-Ahmadie (18)
  6. Maurizio Scaltriti (18)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (7)
  4. 2020 (4)
  5. 2019 (8)
  6. 2018 (7)

More Years

Publications
  1. Modern Pathology (14)
  2. Cancer Research (12)
  3. Laboratory Investigation (11)
  4. Journal of Thoracic Oncology (8)
  5. Clinical Cancer Research (6)
  6. Journal of Clinical Oncology (6)

More Publications

Publishers
  1. Nature Publishing Group (24)
  2. American Association for Cancer Research (23)
  3. Nature Research (15)
  4. Elsevier Inc. (11)
  5. American Society of Clinical Oncology (7)
  6. Oxford University Press (5)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
    Journal Article

    Juric, D.; Castel, P.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ellis, H.; Ebbesen, S. H.; Ainscough, B. J.; Ramu, A.; Iyer, G.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
    Journal Article

    Cheng, D. T.; Mitchell, T. N.; Zehir, A.; Shah, R. H.; Benayed, R.; Syed, A.; Chandramohan, R.; Liu, Z. Y.; Won, H. H.; Scott, S. N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Sequencing analysis of triple negative breast carcinoma (TNBC) with a large central acellular zone (LCAZ)
    Meeting Abstract

    Weisman, P.; Brogi, E.; Won, H.; Akram, M.; Ng, C.; Piscuoglio, S.; Fusco, N.; Weigelt, B.; Reis, J.; Norton, L.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Sequencing analysis of triple negative breast carcinoma (TNBC) with a large central acellular zone (LCAZ)
    Meeting Abstract

    Weisman, P.; Brogi, E.; Won, H.; Akram, M.; Ng, C.; Piscuoglio, S.; Fusco, N.; Weigelt, B.; Reis, J.; Norton, L.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • TSC1 or TSC2 inactivation is a common driving event in tuberous sclerosis-associated renal epithelial neoplasms exhibiting diverse histology
    Meeting Abstract

    Chen, Y. B.; Won, H.; Al-Ahmadie, H.; Gopalan, A.; Fine, S.; Argani, P.; Wang, L.; Berger, M.; Tickoo, S.; Reuter, V.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • TSC1 or TSC2 inactivation is a common driving event in tuberous sclerosis-associated renal epithelial neoplasms exhibiting diverse histology
    Meeting Abstract

    Chen, Y. B.; Won, H.; Al-Ahmadie, H.; Gopalan, A.; Fine, S.; Argani, P.; Wang, L.; Berger, M.; Tickoo, S.; Reuter, V.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis
    Journal Article

    Moreira, A. L.; Won, H. H.; McMillan, R.; Huang, J.; Riely, G. J.; Ladanyi, M.; Berger, M. F.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Loss of PTEN leads to clinical resistance to the PI3K alpha inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Won, H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Griffith, M.; Griffith, O.; Iyer, G.; Sgroi, D.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save